A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.
European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results